Successful management of cutaneous BCG dissemination in a child affected by ...
A possible consequence of this inoculation is the development of infection that ranges from localized lesions, as subcutaneous abscesses in the site of inoculation, to disseminated disease. The majority of patients who develop disseminated disease ...
Nature.com - Mon, 29 Jun 2015 06:41



James Zintak's story: Be The Match registry, bone marrow transplant saves 6 ...
Zintak was diagnosed with Chronic granulomatous disease, a rare blood disease, when he was a toddler. The diagnosis meant his future was uncertain. It was news that had his parents searching for answers. “The only cure was a bone marrow transplant,” ...
ABC15 Arizona - Mon, 22 Jun 2015 16:39



Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers
One critical growth drug has been Actimmune, which is in Phase III trials to combat severe malignant osteopetrosis and Chronic Granulomatous Disease, and is estimated to generate up to $500 million in annual peak sales. As for the high cost of ...
TheStreet.com - Tue, 16 Jun 2015 16:13

Abstract and Introduction
We have recognised granulomatous organising pneumonia (GOP) to be a similar histopathological entity where non-necrotising granulomata are intimately associated with the organising connective tissue. To what degree COP, AFOP and GOP represent distinct ...
Medscape - Tue, 23 Jun 2015 21:07



Md. stem cell research panel approves 29 projects for $9.4M in grants
The commission approved a pre-clinical research award of up to $500,000 over three years to MaxCyte, a Gaithersburg biotechnology company developing treatment for chronic granulomatous disease, a genetic disorder that hinders the immune system.
Baltimore Sun - Wed, 10 Jun 2015 13:02



Working Group to Analyze Treatment and Outcomes for Large Vessel Vasculitis
LVV is typically used to denote the spectrum of primary vasculitides that causes chronic granulomatous inflammation predominantly involving the aorta and its major branches. Common ... There are two distinct factors that make effective clinical ...
MD Magazine - Thu, 25 Jun 2015 13:37

Horizon Pharma plc Initiates Phase 3 Trial of ACTIMMUNE(R) (interferon gamma ...
It is indicated to reduce the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD), a genetic disorder that affects the functioning of some cells of the immune system. In addition, ACTIMMUNE is indicated to ...
MarketWatch - Fri, 05 Jun 2015 03:52

Horizon Pharma (HNZP) Starts Phase III Study on Actimmune - Analyst Blog
Actimmune is already approved in the U.S. for the treatment of patients suffering from two rare diseases - chronic granulomatous disease and severe, malignant osteopetrosis. Currently, Horizon Pharma is working toward expanding the product's label in ...
Nasdaq - Mon, 08 Jun 2015 07:15

Horizon Pharma begins phase 3 trial of Actimmune to treat Friedreich's Ataxia
pharmabiz.com - Mon, 08 Jun 2015 04:26


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014